DE60227113D1 - Kondensierte camptothecine als antitumormittel - Google Patents

Kondensierte camptothecine als antitumormittel

Info

Publication number
DE60227113D1
DE60227113D1 DE60227113T DE60227113T DE60227113D1 DE 60227113 D1 DE60227113 D1 DE 60227113D1 DE 60227113 T DE60227113 T DE 60227113T DE 60227113 T DE60227113 T DE 60227113T DE 60227113 D1 DE60227113 D1 DE 60227113D1
Authority
DE
Germany
Prior art keywords
antitutside
camptothecines
condensate
agent
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60227113T
Other languages
English (en)
Inventor
Takeshi Murata
Satoshi Niizuma
Nobuo Shimma
Hitomi Suda
Masao Tsukazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60227113D1 publication Critical patent/DE60227113D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60227113T 2001-11-30 2002-11-25 Kondensierte camptothecine als antitumormittel Expired - Lifetime DE60227113D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128361 2001-11-30
PCT/EP2002/013216 WO2003045952A2 (en) 2001-11-30 2002-11-25 Condensed camptothecins as antitumor agents

Publications (1)

Publication Number Publication Date
DE60227113D1 true DE60227113D1 (de) 2008-07-24

Family

ID=8179394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60227113T Expired - Lifetime DE60227113D1 (de) 2001-11-30 2002-11-25 Kondensierte camptothecine als antitumormittel

Country Status (29)

Country Link
US (2) US6825194B2 (de)
EP (1) EP1480984B9 (de)
JP (1) JP4305909B2 (de)
KR (1) KR100895746B1 (de)
CN (1) CN100338066C (de)
AT (1) ATE398131T1 (de)
AU (1) AU2002356720B2 (de)
BR (1) BR0214615A (de)
CA (1) CA2468824C (de)
DE (1) DE60227113D1 (de)
ES (1) ES2307830T3 (de)
GT (1) GT200200250A (de)
HK (2) HK1072935A1 (de)
HU (1) HUP0500062A3 (de)
IL (1) IL162058A0 (de)
MX (1) MXPA04005185A (de)
MY (1) MY136138A (de)
NO (1) NO329005B1 (de)
NZ (1) NZ533568A (de)
PA (1) PA8558901A1 (de)
PE (1) PE20030725A1 (de)
PL (1) PL207510B1 (de)
RS (1) RS51051B (de)
RU (1) RU2299212C2 (de)
TW (1) TWI258481B (de)
UA (1) UA80409C2 (de)
UY (1) UY27560A1 (de)
WO (1) WO2003045952A2 (de)
ZA (1) ZA200404522B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1777611A (zh) * 2003-02-21 2006-05-24 中外制药株式会社 制备六环喜树碱衍生物的方法
CA2563502A1 (en) 2004-04-09 2005-10-20 Chugai Seiyaku Kabushiki Kaisha Novel water-soluble prodrug
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CN101340913A (zh) * 2005-10-19 2009-01-07 中外制药株式会社 包含新颖的水溶性前药的胰腺癌、卵巢癌或肝癌的预防或治疗剂
KR102498681B1 (ko) 2019-03-29 2023-02-09 메디뮨 리미티드 화합물 및 이의 접합체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
CA2280905C (en) 1997-02-14 2006-08-29 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives

Also Published As

Publication number Publication date
MY136138A (en) 2008-08-29
GT200200250A (es) 2004-01-15
PE20030725A1 (es) 2003-08-28
RS47004A (en) 2007-02-05
BR0214615A (pt) 2004-09-14
WO2003045952A3 (en) 2003-10-16
UA80409C2 (en) 2007-09-25
EP1480984B1 (de) 2008-06-11
NO20042729L (no) 2004-08-27
RS51051B (sr) 2010-10-31
TWI258481B (en) 2006-07-21
PL207510B1 (pl) 2010-12-31
ATE398131T1 (de) 2008-07-15
RU2004119841A (ru) 2005-03-27
CA2468824A1 (en) 2003-06-05
AU2002356720B2 (en) 2009-01-29
US20050059679A1 (en) 2005-03-17
PL370479A1 (en) 2005-05-30
WO2003045952A2 (en) 2003-06-05
PA8558901A1 (es) 2003-06-30
US6825194B2 (en) 2004-11-30
AU2002356720A1 (en) 2003-06-10
HUP0500062A2 (hu) 2005-04-28
HK1077303A1 (en) 2006-02-10
KR20040062976A (ko) 2004-07-09
TW200408642A (en) 2004-06-01
UY27560A1 (es) 2003-05-30
CA2468824C (en) 2011-01-11
EP1480984A2 (de) 2004-12-01
JP2005511643A (ja) 2005-04-28
CN1617874A (zh) 2005-05-18
NO329005B1 (no) 2010-07-19
HUP0500062A3 (en) 2012-12-28
KR100895746B1 (ko) 2009-04-30
EP1480984B9 (de) 2009-03-11
NZ533568A (en) 2006-01-27
JP4305909B2 (ja) 2009-07-29
US7109195B2 (en) 2006-09-19
US20030144304A1 (en) 2003-07-31
CN100338066C (zh) 2007-09-19
ZA200404522B (en) 2005-01-04
ES2307830T3 (es) 2008-12-01
MXPA04005185A (es) 2004-08-11
RU2299212C2 (ru) 2007-05-20
HK1072935A1 (en) 2005-09-16
IL162058A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
SE9904508D0 (sv) New compounds
HK1089163A1 (en) Quinoxaline derivatives as neutrophil elastase inhibitors and their use
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
NO20054404L (no) 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
HK1068136A1 (en) Muscarinic antagonists
DE60121461D1 (de) Kondensierte pyridoindolderivate
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
SE0102055D0 (sv) New Compounds
PT992509E (pt) Novos derivados macrolidos
MXPA04006041A (es) Antivirales de piridoquinoxalina.
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE287886T1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
DE60112960D1 (de) Kondensierte pyridoindolderivate
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
HK1077303A1 (en) Hexacyclic compounds
SE9803773D0 (sv) Compounds
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ATE324368T1 (de) Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase
DE60103034D1 (de) Neue phenylheteroalkylamin-derivate
YU46302A (sh) Supstituisani piroli
SE9902596D0 (sv) Pharmaceutically active compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition